(2Z)-2-{[3-(1-benzyl-5-methoxy-1H-indol-3-yl)-1-(4-chlorophenyl)-1H-pyrazol-5-yl]imino}-1,3-thiazolidin-4-one

ID: ALA5279119

Max Phase: Preclinical

Molecular Formula: C28H22ClN5O2S

Molecular Weight: 528.04

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  COc1ccc2c(c1)c(-c1cc(/N=C3/NC(=O)CS3)n(-c3ccc(Cl)cc3)n1)cn2Cc1ccccc1

Standard InChI:  InChI=1S/C28H22ClN5O2S/c1-36-21-11-12-25-22(13-21)23(16-33(25)15-18-5-3-2-4-6-18)24-14-26(30-28-31-27(35)17-37-28)34(32-24)20-9-7-19(29)8-10-20/h2-14,16H,15,17H2,1H3,(H,30,31,35)

Standard InChI Key:  PWWHVXTVIFQHRZ-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 37 42  0  0  0  0  0  0  0  0999 V2000
    0.0065    0.9144    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.8315    0.9144    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.0816    0.1105    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4281   -0.3601    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2392    0.1317    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8782   -0.1029    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.0916   -0.8995    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8883   -1.1130    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.9217   -1.9540    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1690   -2.2394    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6518   -1.5918    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    3.6360   -2.3664    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0359   -0.0817    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2493   -0.8782    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0904   -0.9118    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3758   -0.1589    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7281    0.3581    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1449    0.1429    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2693    0.9625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6260    1.4785    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8529    1.1811    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2438    1.6286    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8316    2.3431    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2435    3.0548    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0684    3.0548    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4801    2.3449    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0721    1.6286    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8395    2.2752    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6360    2.4886    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5027   -1.6260    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0904   -2.3402    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4808    3.7690    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -1.2656   -2.3405    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8551   -3.0530    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2676   -3.7674    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0882   -3.7690    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5045   -3.0576    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  1  5  2  0
  5  4  1  0
  3  6  1  0
  6  7  2  0
  8  7  1  0
  8  9  1  0
  9 10  1  0
 11 10  1  0
  7 11  1  0
  9 12  2  0
  5 13  1  0
 14 13  2  0
 14 15  1  0
 15 16  1  0
 17 16  2  0
 13 17  1  0
 16 18  1  0
 19 18  2  0
 20 19  1  0
 21 20  2  0
 17 21  1  0
  2 22  1  0
 23 22  2  0
 24 23  1  0
 25 24  2  0
 26 25  1  0
 27 26  2  0
 22 27  1  0
 20 28  1  0
 28 29  1  0
 15 30  1  0
 30 31  1  0
 25 32  1  0
 33 31  2  0
 34 33  1  0
 35 34  2  0
 36 35  1  0
 37 36  2  0
 31 37  1  0
M  END

Alternative Forms

  1. Parent:

    ALA5279119

    ---

Associated Targets(Human)

BEAS-2B (690 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A549 (127892 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SK-MEL-28 (48833 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCT-116 (91556 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

B16-F10 (4610 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 528.04Molecular Weight (Monoisotopic): 527.1183AlogP: 6.05#Rotatable Bonds: 6
Polar Surface Area: 73.44Molecular Species: NEUTRALHBA: 7HBD: 1
#RO5 Violations: 2HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski): 2
CX Acidic pKa: 7.57CX Basic pKa: 0.76CX LogP: 6.49CX LogD: 6.26
Aromatic Rings: 5Heavy Atoms: 37QED Weighted: 0.29Np Likeness Score: -1.34

References

1. Soni JP, Chilvery S, Sharma A, Reddy GN, Godugu C, Shankaraiah N..  (2023)  Design, synthesis and in vitro cytotoxicity evaluation of indolo-pyrazoles grafted with thiazolidinone as tubulin polymerization inhibitors.,  14  (3): [PMID:36970141] [10.1039/d2md00442a]

Source